Suppr超能文献

抗抑郁药和镇痛药反应之间的关系:六项安慰剂对照试验评估度洛西汀治疗重度抑郁症患者疗效的发现。

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.

机构信息

University of Miami School of Medicine, Miami, FL,USA.

出版信息

Curr Med Res Opin. 2008 Nov;24(11):3105-15. doi: 10.1185/03007990802429627. Epub 2008 Oct 2.

Abstract

OBJECTIVE

Debate continues regarding whether onset of analgesia is faster than antidepressant effect in antidepressants with both properties. Duloxetine hydrochloride (from here on referred to as duloxetine) is effective in both major depressive disorder and diabetic peripheral neuropathic pain. This post-hoc analysis of six placebo-controlled duloxetine trials in patients with major depressive disorder was designed to compare onset of antidepressant activity to pain relief.

RESEARCH DESIGN AND METHODS

Duloxetine was administered at 40-120 mg/day versus placebo for up to 9 weeks in outpatient clinic settings. The primary depression measure was the HAMD(17) and pain severity was measured using visual analog scale (VAS) measuring overall pain, headache, back and shoulder pain, and pain while awake. The time course of improvement was profiled using repeated measures modeling and Kaplan-Meier product limit estimation.

RESULTS

In all but one case, significant reductions in HAMD(17) and VAS scores were seen within 2 weeks of treatment. Median time to VAS response was consistently shorter across all VAS measures than that to HAMD(17) response in both placebo- and duloxetine-treated patients with at least modest levels of pain at study entry. Regression analyses consistently demonstrated little association between analgesic and antidepressant responses. Limitations of these findings include that the studies used in these analyses did not require the patients to enroll with any specific level of pain. Moreover, the type of pain exhibiting at presentation was not routinely identified; therefore, the impact of different pain types on these findings is unknown.

CONCLUSIONS

Duloxetine's analgesic effect is independent of the drug's antidepressant effect. Additionally, faster onset of the analgesic effect appears to be a population-specific phenomenon that is unmodified in the presence of active agents.

摘要

目的

关于同时具有抗抑郁和镇痛作用的抗抑郁药,其镇痛作用是否快于抗抑郁作用,目前仍存在争议。盐酸度洛西汀(下文简称度洛西汀)对重度抑郁症和糖尿病周围神经性疼痛均有效。本项针对六项度洛西汀治疗重度抑郁症安慰剂对照试验的事后分析旨在比较抗抑郁活性的起始与疼痛缓解。

研究设计和方法

度洛西汀 40-120mg/日给药,疗程 9 周,在门诊环境下进行。主要抑郁测量指标为汉密尔顿抑郁量表 17 项(HAMD(17)),疼痛严重程度采用视觉模拟量表(VAS)测量,包括总体疼痛、头痛、腰背和肩部疼痛以及清醒时的疼痛。采用重复测量模型和 Kaplan-Meier 乘积限估计对改善的时间过程进行分析。

结果

除了一项研究外,在治疗的第 2 周内,HAMD(17)和 VAS 评分均显著降低。在至少有中度疼痛的安慰剂和度洛西汀治疗患者中,VAS 各项测量的 VAS 反应时间中位数均始终短于 HAMD(17)反应时间,且在各个 VAS 测量中都如此。回归分析一致表明,镇痛和抗抑郁反应之间几乎没有关联。这些发现的局限性包括这些分析中使用的研究并未要求患者以任何特定的疼痛水平入组。此外,研究开始时表现出的疼痛类型通常未被识别;因此,不同疼痛类型对这些发现的影响尚不清楚。

结论

度洛西汀的镇痛作用与其抗抑郁作用无关。此外,镇痛作用的起始更快似乎是一种人群特异性现象,在存在活性药物时不会改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验